by Jordana Choucair | Jul 29, 2022 | Life Sciences
According to Vizient’s Summer 2022 Pharmacy Market Outlook report, drug price growth will slow next year as biosimilars are expected to curb the price of the world’s best-selling drug. The report found that pharmaceutical prices are projected to increase 3.26...
by Jordana Choucair | Jul 29, 2022 | Life Sciences
he Biden administration is planning a September campaign for reformulated COVID-19 booster shots. The vaccines, which Pfizer Inc. and Moderna Inc. said they could deliver on that timeline, would be available for all adults and potentially children. The companies...
by Jordana Choucair | Jul 29, 2022 | Payers
The Employee Benefit Research Institute found that the growth of high-deductible health plans led to people with employer-sponsored coverage paying for a larger share, on average, of their health care costs between 2013 and 2019. The share of their medical expenses...
by Jordana Choucair | Jul 29, 2022 | Providers
New York state filed a lawsuit against CVS Health Corp for allegedly forcing safety net hospitals to pay millions of dollars to access discounted prescription drugs, violating state antitrust law. According to the lawsuit, CVS forced New York safety net providers to...
by Jordana Choucair | Jul 29, 2022 | Public Health/Prevention
Senate Democrats are seeking $21 billion in new emergency spending on COVID-19 as well as preparedness measures for additional outbreaks, including monkeypox. The bill would appropriate $16 billion for a key Health and Human Services program to be used in the fight...
Recent Comments